Market Research Reports and Industry Reports

Orthobiologics Market by Product (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Orthopedic Clinics) - Global Forecast to 2019

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019.

The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market.

The report has profiled leading players of this market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).

Reasons to Buy the Report:

This comprehensive research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which constitute basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the orthobiologics market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to verify the current market conditions which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a customized combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

• Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies so as to exploit new clientele base and different pricing policies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market

• Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players in order to enhance the bottom line of the companies in the orthobiologics market

• Product/ Brand Perception Analysis: Comprehensive study of customer perception and behavior through our inbuilt social connect tools (digital marketing language) and checking the tenacity of blogs and social forums

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET SEGMENTATION & COVERAGE 11
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET 14
2.1.1 TOP-DOWN APPROACH 14
2.1.2 BOTTOM-UP APPROACH 16
2.1.3 MACROINDICATOR-BASED APPROACH 17
2.2 ASSUMPTIONS 18
3 EXECUTIVE SUMMARY 19
4 MARKET OVERVIEW 21
4.1 INTRODUCTION 21
4.2 MARKET DRIVERS AND INHIBITORS 22
4.3 KEY MARKET DYNAMICS 24
5 ORTHOBIOLOGICS MARKET, BY PRODUCT 25
5.1 INTRODUCTION 26
5.2 GLOBAL ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH PARENT MARKET 27
5.3 GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY 28
5.4 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY 29
5.5 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY 30
5.6 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY GEOGRAPHY 31
5.7 GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY 32
6 ORTHOBIOLOGICS MARKET, BY END-USER 33
6.1 INTRODUCTION 34
6.2 GLOBAL ORTHOBIOLOGICS MARKET HOSPITALS MARKET, BY GEOGRAPHY 35
6.3 GLOBAL ORTHOPEDIC CLINICS MARKET, BY GEOGRAPHY 36
6.4 GLOBAL ORTHOBIOLOGICS OTHER END-USERS MARKET, BY GEOGRAPHY 37
7 ORTHOBIOLOGICS MARKET, BY GEOGRAPHY 38
7.1 INTRODUCTION 39
7.2 NORTH AMERICA ORTHOBIOLOGICS MARKET 40
7.2.1 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT 41
7.2.2 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER 43
7.3 EUROPE ORTHOBIOLOGICS MARKET 44
7.3.1 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT 45
7.3.2 EUROPE ORTHOBIOLOGICS MARKET, BY END-USER 46
7.4 ASIA ORTHOBIOLOGICS MARKET 48
7.4.1 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT 48
7.4.2 ASIA ORTHOBIOLOGICS MARKET, BY END-USER 50
7.5 REST OF THE WORLD (ROW) ORTHOBIOLOGICS MARKET 51
7.5.1 ROW ORTHOBIOLOGICS MARKET, BY PRODUCT 52
7.5.2 ROW ORTHOBIOLOGICS MARKET, BY END-USER 53
8 ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE 55
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS 55
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT 56
8.3 MERGERS & ACQUISITIONS 57
8.4 NEW PRODUCT LAUNCHES 58
8.5 EXPANSIONS 59
8.6 AGREEMENTS 60
8.7 OTHER DEVELOPMENTS 60
9 ORTHOBIOLOGICS MARKET, BY COMPANY 61
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC. 61
9.2 MEDTRONIC PLC 64
9.3 INTEGRA LIFE SCIENCES CORPORATION 66
9.4 STRYKER CORPORATION 70
9.5 ZIMMER, INC. 73
9.6 DEPUY SYNTHES (JOHNSON & JOHNSON FAMILY OF COMPANIES) 76
9.7 TORNIER, INC. 79
9.8 NUVASIVE, INC. 82
9.9 EXACTECH, INC. 85
9.10 GLOBUS MEDICAL INC. 88
9.11 WRIGHT MEDICAL TECHNOLOGY, INC. 91
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 95
10.1 CUSTOMIZATION OPTIONS 95
10.1.1 REGULATORY FRAMEWORK 95
10.1.2 EPIDEMIOLOGY DATA 95
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 95
10.1.4 IMPACT ANALYSIS 95
10.2 RELATED REPORTS 96
10.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 97
10.3.1 RT SNAPSHOTS 98


List Of Tables

TABLE 1 GLOBAL ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN) 15
TABLE 2 GLOBAL ORTHOBIOLOGICS MARKET: MACROINDICATOR, BY COUNTRY, 2014 17
TABLE 3 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET,
2013-2019 (USD MN) 22
TABLE 4 GLOBAL ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS 22
TABLE 5 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 24
TABLE 6 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 26
TABLE 7 GLOBAL ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN) 27
TABLE 8 GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY, 2013–2019 (USD MN) 28
TABLE 9 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 29
TABLE 10 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 30
TABLE 11 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 31
TABLE 12 GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (USD MN) 32
TABLE 13 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013-2019 (USD MN) 34
TABLE 14 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY,
2013-2019 (USD MN) 35
TABLE 15 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (USD MN) 36
TABLE 16 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-USERS, BY GEOGRAPHY,
2013 - 2019 (USD MN) 37
TABLE 17 GLOBAL ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 39
TABLE 18 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 41
TABLE 19 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
TABLE 20 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
TABLE 21 EUROPE ORTHOBIOLOGICS MARKET , BY END-USER, 2013-2019 (USD MN) 47
TABLE 22 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
TABLE 23 ASIA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50
TABLE 24 ROW ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 52
TABLE 25 ROW ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 54
TABLE 26 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 55
TABLE 27 GLOBAL ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS 57
TABLE 28 GLOBAL ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES 58
TABLE 29 GLOBAL ORTHOBIOLOGICS MARKET: EXPANSIONS 59
TABLE 30 GLOBAL ORTHOBIOLOGICS MARKET: AGREEMENTS 60
TABLE 31 GLOBAL ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS 60
TABLE 32 BIOMET, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 62
TABLE 33 MEDTRONIC, PLC.: KEY FINANCIALS, 2009-2013 (USD MN) 64
TABLE 34 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (USD MN) 67
TABLE 35 STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (USD MN) 70
TABLE 36 ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 74
TABLE 37 DEPUY SYNTHES: KEY FINANCIALS, 2011-2013 (USD MN) 77
TABLE 38 TORNIER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 80
TABLE 39 NUVASIVE, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 82
TABLE 40 EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 86
TABLE 41 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 88
TABLE 42 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 92


List Of Figures

FIGURE 1 GLOBAL ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE 12
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM 14
FIGURE 3 TOP-DOWN APPROACH 15
FIGURE 4 BOTTOM-UP APPROACH 16
FIGURE 5 MACROINDICATOR-BASED APPROACH 17
FIGURE 6 GLOBAL ORTHOBIOLOGICS MARKET SNAPSHOT 20
FIGURE 7 GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET 22
FIGURE 8 GLOBAL ORTHOBIOLOGICS PRODUCTS, BY GEOGRAPHY, 2014 (USD MN) 24
FIGURE 9 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 26
FIGURE 10 GLOBAL ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN) 27
FIGURE 11 GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY, 2013–2019 (USD MN) 28
FIGURE 12 GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 29
FIGURE 13 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 30
FIGURE 14 GLOBAL BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY GEOGRAPHY, 2013-2019 (USD MN) 31
FIGURE 15 GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY, 2013–2019 (USD MN) 32
FIGURE 16 GLOBAL ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 34
FIGURE 17 GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY,
2013-2019 (USD MN) 35
FIGURE 18 GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (USD MN) 36
FIGURE 19 GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-USERS, BY GEOGRAPHY,
2013-2019 (USD MN) 37
FIGURE 20 GLOBAL ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY GEOGRAPHY,
2014-2019 (USD MN) 39
FIGURE 21 NORTH AMERICA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 40
FIGURE 22 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 41
FIGURE 23 NORTH AMERICA: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 42
FIGURE 24 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
FIGURE 25 NORTH AMERICA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT (%) 44
FIGURE 26 EUROPE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 44
FIGURE 27 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
FIGURE 28 EUROPE ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 46
FIGURE 29 EUROPE ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 46
FIGURE 30 EUROPE: ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 47
FIGURE 31 ASIA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 48
FIGURE 32 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 48
FIGURE 33 ASIA ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 49
FIGURE 34 ASIA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50
FIGURE 35 ASIA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 51
FIGURE 36 ROW ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 51
FIGURE 37 ROW ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 52
FIGURE 38 ROW ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 53
FIGURE 39 ROW ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 53
FIGURE 40 ROW ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 54
FIGURE 41 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 55
FIGURE 42 ORTHOBIOLOGICS: COMPANY PRODUCT COVERAGE, 2013 56
FIGURE 43 BIOMET, INC.: REVENUE MIX, 2013 (%) 61
FIGURE 44 CONTRIBUTION OF SPINE, BONE HEALING, AND MICROFIXATION SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN) 62
FIGURE 45 MEDTRONIC, PLC. REVENUE MIX, 2013 (%) 64
FIGURE 46 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 65
FIGURE 47 INTEGRA LIFE SCIENCES CORPORATION REVENUE MIX, 2013 (%) 66
FIGURE 48 CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2010-2013 (USD MN) 67
FIGURE 49 STRYKER CORPORATION REVENUE MIX, 2013 (%) 70
FIGURE 50 CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 71
FIGURE 51 ZIMMER, INC.: REVENUE MIX, 2013 (%) 73
FIGURE 52 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 74
FIGURE 53 DEPUY SYNTHES REVENUE MIX, 2013 (%) 76
FIGURE 54 TORNIER, INC.: REVENUE MIX 2013 (%) 79
FIGURE 55 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUES,
2009-2013 (USD MN) 80
FIGURE 56 NUVASIVE, INC.: REVENUE MIX 2013 (%) 82
FIGURE 57 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES,
2009 - 2013 (USD MN) 83
FIGURE 58 EXACTECH, INC.: REVENUE MIX 2013 (%) 85
FIGURE 59 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 86
FIGURE 60 GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%) 88
FIGURE 61 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 89
FIGURE 62 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%) 91
FIGURE 63 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2011 - 2013 (USD MN) 92


Global Orthobiologics Market Research Report 2016

2016 Global Orthobiologics Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Orthobiologics industry, focusing on the main regions (North America,

USD 2850View Report

Global Orthobiologics Market Report 2016

2016 Global Orthobiologics Report is a professional and in-depth research report on The worlds major regional market conditions of The Orthobiologics industry, focusing on The main regions (North America, Europe

USD 2850View Report

Europe Orthobiologics Industry 2016 Market Research Report

The Europe Orthobiologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Orthobiologics industry.The report provides a basic overview of the industry

USD 3600View Report

Syringes Market by Usability - Global Forecast to 2021

Syringes Market by Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes), Type (General & Specialized Syringes (insulin, tuberculin) - Global Forecast to 2021

USD 5650View Report

GFRP Composites Market By Resin Type - Global Forecast To 2026

GFRP Composites Market By Resin Type (Polyester, Vinyl Ester, Epoxy, Polyurethane), Manufacturing Process (Manual Process, Compression Molding, Continuous Process, Injection Molding), Application (Wind Energy, Transportation, Marine, Pipe & Tanks) By

USD 5650View Report

Global Orthobiologics Market Research Report 2016

2016 Global Orthobiologics Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Orthobiologics industry, focusing on the main regions (North America,

USD 2850View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4250
  • Multi User Licence    $ 5150
  • Corporate Licence    $ 7225
  • Enterprise Wide Licence    $ 8150
$ 4250

Reports Details

Published Date : Apr 2015
No. of Pages :99
Country :Global
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment